Rhythm

Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5

Software improvements further leverage the system’s unique ultrasound capabilities for non-contact anatomy reconstruction CARLSBAD, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the full commercial release of AcQMap […]

Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a multi-year agreement with Pfizer, Inc. for Anumana to develop an artificial intelligence […]

Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) — – BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary […]

BIOTRONIK Enrolls First Patient Into BIO-CONDUCT, First IDE Trial to Study Use of Stylet-Driven Leads for Conduction System Pacing

LAKE OSWEGO, Ore., Dec. 12, 2022 /PRNewswire/ — BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA approved investigational device exemption (IDE) trial examining the use of the BIOTRONIK Solia S pacing lead when implanted in the […]

Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias

CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /PRNewswire/ — Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation (PFA) therapy integrated seamlessly with 3D mapping & navigation. Both teams will harness decades of experience in pioneering novel PFA and navigation product […]

AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award

Recognizes Exemplary Board Practices Related to DE&I MASON, Ohio–(BUSINESS WIRE)–AtriCure Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has been named a winner of the 2022 Diversity, Equity & Inclusion Award […]

HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device

Partnership Positions AIMIGo for Early Market Testing in Q2 2023 After Expected FDA Clearance December 07, 2022 08:31 AM Eastern Standard Time SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, today […]

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

The flagship 3D mapping catheter from Acutus Medical has been certified under the new European Medical Device Regulations CARLSBAD, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or “the Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, […]